Physicians' Academy for Cardiovascular Education

HoFH: Prevalence and new treatments

3' education - Sep. 1, 2013 - Snapshot 2013 - Dr Kees Hovingh

Dr. Kees Hovingh, AMC, Amsterdam, reviews recent data on the prevalence, phenotype and novel treatment options for patients with Homozygous Familial Hypercholesterolaemia.

Share this page with your colleagues and friends: